文献速递腹部CT

双能CT细胞外容积分数揭示肝纤维化病因学差异

Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosis.
PubMed 文献 · Abdom Radiol (NY) · 2023-03-20

本研究纳入166例正常肝脏及病毒性肝炎、酒精性、非酒精性脂肪性肝炎相关慢性肝病患者,行双能CT平衡期扫描计算细胞外容积分数(ECV)。结果显示各病因ECV随纤维化分期增加而升高,且酒精性肝病在F2-F4期ECV显著高于其他病因,病因差异影响纤维化分期诊断效能。

要点

  • ECV随METAVIR纤维化分期增加而升高,与分期呈强或中等相关。
  • F2-F4期酒精性肝病ECV显著高于病毒性肝炎和NASH,F1期无差异。

核心结论

  • 晚期纤维化阶段酒精性肝病ECV高于其他病因,病因学差异影响ECV对纤维化分期的诊断效能。

研究设计与样本

  • 回顾性研究,纳入166例患者(正常肝脏14例,病毒性肝炎71例,酒精性44例,NASH 37例),行双能CT肝脏5分钟平衡期扫描,以METAVIR纤维化分期为参考标准。

关键影像表现/征象

  • ECV在各病因及全部患者中随纤维化分期升高而显著增加(p < 0.001)。
  • F2-F4期酒精性肝病ECV显著大于病毒性肝炎和NASH(p < 0.05),F1期三种病因间无显著差异。

诊断标准与关键数值

  • 全部患者ECV与纤维化分期的Spearman相关系数为0.701,病毒性肝炎0.638,酒精性0.885,NASH 0.791。
  • 酒精性肝病鉴别≥F1的cutoff为20.1%、AUC-ROC 0.708;≥F2为23.8%、0.990;≥F3为24.3%、0.968;≥F4为26.6%、0.961。

临床应用与阅片要点

  • 阅片时需结合肝病病因解读ECV值,酒精性肝病患者ECV阈值可能需上调。
  • ECV可用于无创评估纤维化分期,但病因差异可能影响诊断准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess etiological differences in extracellular volume fraction (ECV) and evaluate its influence on staging performance.

METHODS: A total of 166 patients with normal liver (n = 14) and chronic liver disease related to viral hepatitis (n = 71), alcohol (n = 44), and nonalcoholic steatohepatitis (NASH) (n = 37) underwent dual-energy CT (DECT) of the liver (5-min equilibrium-phase images) between January 2020 and July 2022. The iodine densities of the parenchyma and aorta were measured and ECV was calculated. Comparisons of ECV between each etiology and METAVIR fibrosis stage were statistically analyzed (p < 0.05).

RESULTS: ECV in each etiology and all patients significantly increased with higher fibrosis stage (p < 0.001) and showed a strong or moderate correlation with fibrosis stage (Spearman's ρ; all patients, 0.701; viral hepatitis, 0.638; alcoholic, 0.885; NASH, 0.791). In stages F2-F4, ECV in alcoholic liver disease was significantly larger than those for viral hepatitis and NASH (p < 0.05); however, no significant difference in stage F1 was found among the three etiologies. The cutoff values and areas under the receiver operating characteristic curve (AUC-ROCs) for discriminating fibrosis stage (≥ F1- ≥ F4) were higher for alcohol (cutoff values and AUC-ROC; 20.1% and 0.708 for ≥ F1, 23.8% and 0.990 for ≥ F2, 24.3% and 0.968 for ≥ F3, and 26.6% and 0.961 for ≥ F4, respectively) compared with those for the others.

CONCLUSION: ECV in alcoholic liver disease is higher than that in other etiologies in the advanced stages of fibrosis, and etiological differences in ECV affect the staging performance of fibrosis.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ozaki, Ohtani, Ishida, et al. Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosis. Abdom Radiol (NY). 2023. PMID: 36939910. doi:10.1007/s00261-023-03873-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。